Aria CV Overview
- Founded
-
2010
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7.77M
- Investors
-
12
Aria CV General Information
Description
Developer of implantable cardiovascular devices designed to treat pulmonary hypertension. The company's devices reduce the workload on the heart and have the potential to enhance both the survival and quality of life of those suffering from pulmonary hypertension, enabling patients to improve outcomes by reducing the workload on the right side of the heart.
Contact Information
Website
www.ariacv.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- 2334 University Avenue West
- Suite 190
- Saint Paul, MN 55114
- United States
+1 (651) 000-0000
Aria CV Timeline
Aria CV Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 18-Jul-2022 | $7.77M | 000.00 | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | 17-Jun-2021 | 000.00 | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series B) | 25-Feb-2020 | $31M | $38.8M | 0000 | Completed | Clinical Trials - Phase 4 |
| 1. Early Stage VC (Series A) | 07-Jul-2015 | $7.8M | $7.8M | 000.00 | Completed | Clinical Trials - Phase 4 |
Aria CV Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Aria CV Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of implantable cardiovascular devices designed to treat pulmonary hypertension. The company's devices reduce t
Therapeutic Devices
Saint Paul, MN
18
As of 2023
000.00
0000000000 0
000.00
000000
on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
00000000000 0000000
Milan, Italy
00
As of 0000
000.00
00000000000
000.00
000000
it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
00000000000 0000000
Kirkland, WA
00
As of 0000
00000
00000000000
00000
Add Comparison
Aria CV Competitors (19)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InnovHeart | Venture Capital-Backed | Milan, Italy | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 0000000000 | Venture Capital-Backed | Kirkland, WA | 00 | 00000 | 00000000000 | 00000 |
| 00000000 (00000000 | Venture Capital-Backed | Paris, France | 00 | 0000 | 00000000000 | 0000 |
| 000000000 00000000 | Private Equity-Backed | Irvine, CA | 000 | 00000 | 0000000 0000 | 00000 |
| 0000000 | Venture Capital-Backed | Herzliya, Israel | 00 | 000.00 | 0000000000 0 | 000.00 |
Aria CV Patents
Aria CV Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210402159-A1 | Implantable devices for reducing pulsatile pressure within a blood vessel | Pending | 25-Jun-2020 | 0000000000 | |
| EP-4025287-A1 | Diffusion and infusion resistant implantable devices for reducing pulsatile pressure | Pending | 06-Sep-2019 | 0000000000 | |
| US-20220023614-A1 | Diffusion and infusion resistant implantable devices for reducing pulsatile pressure | Pending | 06-Sep-2019 | 0000000000 | |
| US-20210069396-A1 | Diffusion and infusion resistant implantable devices for reducing pulsatile pressure | Active | 06-Sep-2019 | 0000000000 | |
| US-11141581-B2 | Diffusion and infusion resistant implantable devices for reducing pulsatile pressure | Active | 06-Sep-2019 | A61M60/869 |
Aria CV Executive Team (7)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Karl Vollmers Ph.D | Co-Founder, Chief Technology Officer & Vice President of Research & Development | ||
| John Scandurra | Co-Founder & Chief Scientific Officer | ||
| Dan Gladney | Chief Executive Officer, President & Board Member | ||
| Peter Delange | Chief Technology Officer | ||
| Darshana Zaveri | Chairman |
Aria CV Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dan Gladney | Self | Chief Executive Officer, President & Board Member | 000 0000 |
| Darshana Zaveri | Self | Chairman | 000 0000 |
| George Fazio | Self | Board Member | 000 0000 |
| Jason Rushton | Self | Board Member | 000 0000 |
| Maria Berkman MD | Broadview Ventures | Board Member | 000 0000 |
Aria CV Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Aria CV Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
| Angel Physicians Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Brightstone Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Frontcourt Group | Investment Bank | Minority | 000 0000 | 000000 0 | |
| Long View Equity Partners | Asset Manager | Minority | 000 0000 | 000000 0 |